Thank you for subscribing to our blog.
We’ll hit your inbox next week with our latest post.

Latest Insights and Updates Delivered to your Inbox!

Subscribe now for exciting weekly industry news!

Consumer Healthcare Product Safety: What now, Where Next?
The inaugural Consumer Healthcare (CHC) Safety Roundtable, hosted by Navitas pvnetworks and led by industry leaders Dr. Latika Sharma, MBBS, MD, Ben Parsons, and Dr. Sara Hall, PhD, served as a pivotal gathering for discussing the evolving landscape of consumer healthcare product safety. In this exclusive event, distinguished industry experts, Viny...
Parkinson’s Foundation’s PD GENEration Study: Strategic Partnership with Navitas Life Sciences
As the world observes World Parkinson’s Day on April 11th, a day dedicated to raising awareness about Parkinson’s disease and honouring Dr. James Parkinson, who first described the condition in 1817, the spotlight turns to groundbreaking initiatives that harness genetic research to transform patient care. One such initiative, PD GENEr...
World Health Day 2025: Maternal and Newborn Health
On April 7, 2025, we join the World Health Organisation, under the banner of Healthy beginnings, hopeful futures. The World Health Day 2025 campaign urges stakeholders to take decisive action against preventable maternal and newborn deaths. Over 300,000 women lose their lives annually due to pregnancy or childbirth, and 4 million newborns die or ar...
Reimagining Medical Writing – Data, Digital, and Automation
The pharmaceutical industry is experiencing a paradigm shift in medical writing, driven by artificial intelligence (AI), structured content authoring, and automation. Navitas Life Sciences’ 3rd Medical Writing Roundtable, hosted by Dr Latika Sharma and Dr. Sara Giadrossi, brought together industry leaders from 10+ global pharmaceutical compa...
Driving Digital Innovation in Regulatory Submissions with Navitas Life Sciences
The pharmaceutical industry is undergoing a significant transformation driven by digital innovation and artificial intelligence (AI). It has become increasingly beneficial to leverage AI powered tools and cloud based regulatory solutions to streamline regulatory submissions. These advancements enhance efficiency, improve data exchange, and ensure c...
Navitas Recognized with EcoVadis Bronze Medal for Excellence in Sustainability
In January 2025, we were honoured with the EcoVadis Bronze Medal for our sustainability initiatives. This recognition affirms our dedication to sustainability and strengthens our position as a leading CRO that integrates responsible business practices into every aspect of clinical trials. "We take great pride in integrating ESG principles into our ...
Navitas Life Sciences: Women and Girls in STEM
Every year, February 11 marks the International Day of Women and Girls in Science, a day dedicated to recognizing the contributions of women in science, technology, engineering, and mathematics (STEM). The Gender Gap in Science: Challenges and Progress Despite the groundbreaking work of female scientists like Marie Curie, Rosalind Franklin, and Tu ...
World Cancer Day: Oncology Clinical Trials
At Navitas Life Sciences, we stand as a leading oncology CRO, delivering cutting edge solutions that optimize trial design, enhance patient recruitment, and accelerate regulatory approvals. With over 100 oncology clinical studies conducted, we bring deep expertise in solid and hematological tumors, including breast, lung, gastric, HCC, prostate, mu...
What is a CRO?
What is a CRO? A Contract Research Organization (CRO) is a strategic partner to pharmaceutical, biotechnology, and medical device companies, providing outsourced research activities that facilitate the efficient execution of clinical trials and regulatory processes. CROs offer expertise across clinical development, regulatory affairs, pharmacovigil...
Glaucoma Clinical Trials: Awareness and Future Advancements
Glaucoma remains a leading cause of irreversible blindness worldwide, affecting millions of people and posing significant challenges for healthcare systems. Despite advancements in diagnostics and treatment, the complexity of the disease—characterized by its silent progression and multifactorial nature—demands a continuous evolution i...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us